Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125682681 | 12568268 | 1 | I | 201602 | 20160712 | 20160718 | 20160718 | EXP | FR-ABBVIE-16P-056-1677460-00 | ABBVIE | 58.00 | YR | M | Y | 63.00000 | KG | 20160718 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125682681 | 12568268 | 1 | PS | NORVIR | RITONAVIR | 1 | Oral | UNKNOWN | 22417 | 100 | MG | TABLET | BID | ||||||
| 125682681 | 12568268 | 2 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | Y | UNKNOWN | 0 | 1 | DF | TABLET | QD | |||||
| 125682681 | 12568268 | 3 | SS | DIAZEPAM. | DIAZEPAM | 1 | Oral | Y | UNKNOWN | 0 | 10 | MG | TID | ||||||
| 125682681 | 12568268 | 4 | SS | BACLOFENE | BACLOFEN | 1 | Oral | Y | UNKNOWN | 0 | 10 | MG | BID | ||||||
| 125682681 | 12568268 | 5 | SS | KIVEXA | ABACAVIR SULFATELAMIVUDINE | 1 | Oral | UNKNOWN | 0 | 1 | DF | ||||||||
| 125682681 | 12568268 | 6 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | UNKNOWN | 0 | 600 | MG | BID | |||||||
| 125682681 | 12568268 | 7 | SS | KEPPRA | LEVETIRACETAM | 1 | Oral | Y | UNKNOWN | 0 | |||||||||
| 125682681 | 12568268 | 8 | SS | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | Oral | UNKNOWN | 0 | 200 | MG | BID | |||||||
| 125682681 | 12568268 | 9 | SS | PERINDOPRIL | PERINDOPRIL | 1 | Oral | UNKNOWN | 0 | 2 | MG | QD | |||||||
| 125682681 | 12568268 | 10 | SS | METFORMINE | METFORMIN HYDROCHLORIDE | 1 | Oral | Y | UNKNOWN | 0 | |||||||||
| 125682681 | 12568268 | 11 | C | UVEDOSE | CHOLECALCIFEROL | 1 | Oral | 0 | 100000 | IU |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125682681 | 12568268 | 1 | HIV infection |
| 125682681 | 12568268 | 2 | Product used for unknown indication |
| 125682681 | 12568268 | 3 | Product used for unknown indication |
| 125682681 | 12568268 | 4 | Product used for unknown indication |
| 125682681 | 12568268 | 5 | Product used for unknown indication |
| 125682681 | 12568268 | 6 | Product used for unknown indication |
| 125682681 | 12568268 | 7 | Product used for unknown indication |
| 125682681 | 12568268 | 8 | Product used for unknown indication |
| 125682681 | 12568268 | 9 | Product used for unknown indication |
| 125682681 | 12568268 | 10 | Product used for unknown indication |
| 125682681 | 12568268 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125682681 | 12568268 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125682681 | 12568268 | Cholestasis | |
| 125682681 | 12568268 | Hepatocellular injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125682681 | 12568268 | 2 | 20160226 | 0 | ||
| 125682681 | 12568268 | 3 | 20160226 | 0 | ||
| 125682681 | 12568268 | 4 | 20160217 | 0 | ||
| 125682681 | 12568268 | 10 | 20160209 | 0 |